Xuzhou Central Hospital, The Affiliated XuZhou Hospital of Medical College of Southeast University, Xuzhou, Jiangsu, P.R. China.
Xinyi People's Hospital, Xinyi, Xuzhou, Jiangsu, P.R. China.
Mol Cancer Res. 2019 Sep;17(9):1777-1786. doi: 10.1158/1541-7786.MCR-19-0375. Epub 2019 Jul 15.
Yes-associated protein (YAP)/WW domain-containing transcription regulator 1 (TAZ) is an important transcriptional regulator and effector of the Hippo signaling pathway that has emerged as a critical determinant of malignancy in many human tumors. YAP/TAZ expression regulates the cross-talk between immune cells and tumor cells in the tumor microenvironment through its influence on T cells, myeloid-derived suppressor cells, and macrophages. However, the mechanisms underlying these effects are poorly understood. An improved understanding of the role of YAP/TAZ in tumor immunity is essential for exploring innovative tumor treatments and making further breakthroughs in antitumor immunotherapy. This review primarily focuses on the role of YAP/TAZ in immune cells, their interactions with tumor cells, and how this impacts on tumorigenesis, progression, and therapy resistance.
Yes 相关蛋白 (YAP)/WW 结构域包含转录调节剂 1 (TAZ) 是 Hippo 信号通路的一个重要转录调节剂和效应物,已成为许多人类肿瘤恶性程度的关键决定因素。YAP/TAZ 的表达通过其对 T 细胞、髓源性抑制细胞和巨噬细胞的影响来调节肿瘤微环境中免疫细胞与肿瘤细胞之间的串扰。然而,这些影响的机制尚不清楚。深入了解 YAP/TAZ 在肿瘤免疫中的作用对于探索创新的肿瘤治疗方法和在抗肿瘤免疫治疗方面取得进一步突破至关重要。本综述主要关注 YAP/TAZ 在免疫细胞中的作用、它们与肿瘤细胞的相互作用以及这如何影响肿瘤发生、进展和治疗耐药性。